Lista de obras - Gretja Schnell - Dominio Público Uruguay

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir

artículo científico publicado en 2015

Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children

artículo científico publicado en 2012

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection

artículo científico publicado en 2009

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

artículo científico publicado en 2009

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

artículo científico publicado en 2015

Correction: Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells

artículo científico publicado en 2013

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

artículo científico publicado en 2009

HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types ⬇️

artículo científico publicado el 6 de octubre de 2011

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir

artículo científico publicado en 2015

Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells

artículo científico publicado en 2013

Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes

artículo científico publicado en 2008

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

artículo científico publicado en 2017

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

artículo científico publicado en 2017

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

artículo científico publicado en 2015

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial

artículo científico

Phenotypic Correlates of HIV-1 Macrophage Tropism

artículo científico publicado en 2015

Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities

artículo científico publicado en 2013

Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir

artículo científico publicado en 2015

Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.

artículo científico publicado en 2012

Lista de obras de Gretja Schnell

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir

Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

Correction: Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types ⬇️

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir

Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells

Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial

Phenotypic Correlates of HIV-1 Macrophage Tropism

Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities

Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir

Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.